Effects of the Oral Care With Vaccines for Pneumonia in Elderly; Going Home Together Both Physician and Dentist

Summary

Prospective study comparing the effects of interventions (combined oral care and pneumococcal plus influenza vaccinations) in preventing pneumonia and increasing the survival rate from pneumonia.

Conditions

• Pneumonia

Interventions

BIOLOGICAL

Pneumococcal vaccination (Pneumovax NP, 21800AMY10131000)

Injection,subcutaneous,0.5ml,ones,Planned duration of intervention:a day

BIOLOGICAL

Influenza vaccination (Flubik HA, 16100EZZ01207000)

Injection,subcutaneous,0.5ml,ones,Planned duration of intervention:a day

BIOLOGICAL

Influenza vaccination (Flubik HA, 16100EZZ01207000)

Injection,subcutaneous,0.5ml,ones,Planned duration of intervention:a day

OTHER

Specific frequency of oral care

1 dentist and 2 dental hygienists visited the nursing home once a week. After the residents agreed our receive oral care, the dentist/dental hygienist spent 15 minutes with brushing of teeth, scaling, oral wiping, gargling and cleaning of dentures, to reduce dental plaque which is oral bacteria mechanically by using cleaning tools, including toothbrush, interdental brush, dental scaler, tongue brush, and sponge brush to treatment of periodontal disease at the washstand in their private room primary care physicians. At the same time, they taught and recorded to the nursing care workers the methods of administering responsible oral care to dye for dental plaque by using plaque disclosing agent material.

Sponsors & Collaborators

• Health Research Foundation

  collaborator OTHER

• Yubari Kibounomori

  lead OTHER

Principal Investigators

• Hirofumi Hashimoto, M.D.,Ph.D. · Yubari Health Care Research Center

• Masahiro Hatta, D.D.S. · Yubari Kibounomori

• Takahiro Ichiki, M.D. · Mukawa town National Health Insurance Hobetsu clinic

• Katsushi Nagamori, M.D. · Yubari Health Care Research Center

• Hiroyuki Morita, M.D. · Yubari Health Care Research Cente

• Masako Hatta, D.D.S. · Yubari Health Care Research Center

• Tomohiko Murakami, M.D. · Yubari Kibounomori

Study Design

Allocation

NON_RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Model

PARALLEL

Eligibility

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2009-11-30

Primary Completion

2010-10-31

Completion

2010-10-31

Countries

• Japan

Study Locations